Elbio is preparing and conducting saftety tests, efficacy tests and phamacokinetics tests of the 'Targeting Nano Anti-Cancer Drug' with 2 USA patents. Also Elbio is developing an 'Targeting Anti-Cancer Drug' to kill cancer stem cells using CRISPRs and gene carriers of nanochains.
Elbio will apply to KFDA for IND of 'Artificial Eardrum' for treating acute/chronic tympanic membrane perforation of otitis media.
Elbio will apply to KFDA for the dental product permission of the developed "Bone Graft Material' after GMP approval.
Elbio is developing '3D Bioprinters' and 'Hydrogels' for tissue engineering.
